FSIP1 and breast carcinoma: To characterize the function of FSIP1 in breast cancer where it is frequently upregulated, CRISPR/CAS9 based lentivirus was used to knockout FSIP1 in two breast cancer cell lines SKBR3 and MDA-MB-231 cells, which have a high endogenous expression of FSIP1.